Ambeas interim report January- March 2023 MarketScreener - Marketscreener.com
| AMBEA Stock | SEK 96.00 0.15 0.16% |
Slightly above 55% of Ambea AB's investor base is interested to short. The analysis of current outlook of investing in Ambea AB suggests that many traders are impartial regarding Ambea AB's prospects. Ambea AB's investing sentiment can be driven by a variety of factors including economic data, Ambea AB's earnings reports, geopolitical events, and overall market trends.
Ambea AB stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ambea daily returns and investor perception about the current price of Ambea AB as well as its diversification or hedging effects on your existing portfolios.
Ambea |
Ambeas interim report January- March 2023 MarketScreener Marketscreener.com
Read at news.google.com
 |
Ambea AB Fundamental Analysis
We analyze Ambea AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambea AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambea AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Ambea AB is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Ambea AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ambea AB stock to make a market-neutral strategy. Peer analysis of Ambea AB could also be used in its relative valuation, which is a method of valuing Ambea AB by comparing valuation metrics with similar companies.
Peers
Ambea AB Related Equities
| BIOA-B | BioArctic | 2.99 | ||||
| HNSA | Hansa Biopharma | 0.12 | ||||
| CANTA | Cantargia | 1.64 | ||||
| ONCO | Oncopeptides | 2.37 | ||||
| BINV | BioInvent International | 2.71 |
Additional Tools for Ambea Stock Analysis
When running Ambea AB's price analysis, check to measure Ambea AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ambea AB is operating at the current time. Most of Ambea AB's value examination focuses on studying past and present price action to predict the probability of Ambea AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ambea AB's price. Additionally, you may evaluate how the addition of Ambea AB to your portfolios can decrease your overall portfolio volatility.